id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-1234-0006,FDA,FDA-2014-E-1234,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-11-16T05:00:00Z,2016,11,2016-11-16T05:00:00Z,,2016-11-16T17:12:55Z,,0,0,0900006482399cca
FDA-2014-E-1234-0005,FDA,FDA-2014-E-1234,"Determination of Regulatory Review Period for Purposes of Patent
Extension; INVOKANA",Notice,Determinations,2016-03-01T05:00:00Z,2016,3,2016-03-01T05:00:00Z,2016-05-03T03:59:59Z,2016-03-01T14:31:22Z,2016-04369,0,0,0900006481e95106
FDA-2014-E-1234-0004,FDA,FDA-2014-E-1234,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-12-31T05:00:00Z,2015,12,2015-12-31T05:00:00Z,,2015-12-31T16:38:33Z,,0,0,0900006481ddf68c
FDA-2014-E-1234-0003,FDA,FDA-2014-E-1234,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-05-12T04:00:00Z,2015,5,2015-05-12T04:00:00Z,,2015-05-12T15:46:56Z,,0,0,0900006481adbf3b
FDA-2014-E-1234-0001,FDA,FDA-2014-E-1234,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2014-08-25T04:00:00Z,2014,8,2014-08-25T04:00:00Z,,2014-08-25T12:29:36Z,,0,0,0900006481841bd0
FDA-2014-E-1234-0002,FDA,FDA-2014-E-1234,Patent Extension Application from Birch Stewart Kolasch & Birch LLP (on behalf of Mitsubishi Tanabe Pharma Corporation),Other,Application,2014-08-25T04:00:00Z,2014,8,2014-08-25T04:00:00Z,,2014-08-25T12:29:42Z,,0,0,0900006481841ca2